# The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

> **NCT00827554** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 100 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** LMWH
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT00827554
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827554, "The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00827554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*